310 related articles for article (PubMed ID: 34813879)
21. Application of methyl methacrylate copolymers to the development of transdermal or loco-regional drug delivery systems.
Cilurzo F; Selmin F; Gennari CG; Montanari L; Minghetti P
Expert Opin Drug Deliv; 2014 Jul; 11(7):1033-45. PubMed ID: 24766369
[TBL] [Abstract][Full Text] [Related]
22. Microneedles for Extended Transdermal Therapeutics: A Route to Advanced Healthcare.
Pahal S; Badnikar K; Ghate V; Bhutani U; Nayak MM; Subramanyam DN; Vemula PK
Eur J Pharm Biopharm; 2021 Feb; 159():151-169. PubMed ID: 33388372
[TBL] [Abstract][Full Text] [Related]
23. Solid-State Stability Issues of Drugs in Transdermal Patch Formulations.
Sharma PK; Panda A; Pradhan A; Zhang J; Thakkar R; Whang CH; Repka MA; Murthy SN
AAPS PharmSciTech; 2018 Jan; 19(1):27-35. PubMed ID: 28895101
[TBL] [Abstract][Full Text] [Related]
24. Design, characterization, and modeling of a chitosan microneedle patch for transdermal delivery of meloxicam as a pain management strategy for use in cattle.
Castilla-Casadiego DA; Carlton H; Gonzalez-Nino D; Miranda-Muñoz KA; Daneshpour R; Huitink D; Prinz G; Powell J; Greenlee L; Almodovar J
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111544. PubMed ID: 33255096
[TBL] [Abstract][Full Text] [Related]
25. Mussel-inspired poly(hydroxyethyl acrylate-co-itaconic acid)-catechol/hyaluronic acid drug-in-adhesive patches for transdermal delivery of ketoprofen.
Arunprasert K; Pornpitchanarong C; Rojanarata T; Ngawhirunpat T; Opanasopit P; Patrojanasophon P
Int J Pharm; 2022 Dec; 629():122362. PubMed ID: 36379396
[TBL] [Abstract][Full Text] [Related]
26. A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin.
Seong KY; Seo MS; Hwang DY; O'Cearbhaill ED; Sreenan S; Karp JM; Yang SY
J Control Release; 2017 Nov; 265():48-56. PubMed ID: 28344013
[TBL] [Abstract][Full Text] [Related]
27. Permeability test for transdermal and local therapeutic patches using Skin PAMPA method.
Vizserálek G; Berkó S; Tóth G; Balogh R; Budai-Szűcs M; Csányi E; Sinkó B; Takács-Novák K
Eur J Pharm Sci; 2015 Aug; 76():165-72. PubMed ID: 25957747
[TBL] [Abstract][Full Text] [Related]
28. Development, Evaluation, and Pharmacokinetic Assessment of Polymeric Microarray Patches for Transdermal Delivery of Vancomycin Hydrochloride.
Ramadon D; Permana AD; Courtenay AJ; McCrudden MTC; Tekko IA; McAlister E; Anjani QK; Utomo E; McCarthy HO; Donnelly RF
Mol Pharm; 2020 Sep; 17(9):3353-3368. PubMed ID: 32706591
[TBL] [Abstract][Full Text] [Related]
29. 3D printed microneedles for transdermal drug delivery: A brief review of two decades.
Elahpour N; Pahlevanzadeh F; Kharaziha M; Bakhsheshi-Rad HR; Ramakrishna S; Berto F
Int J Pharm; 2021 Mar; 597():120301. PubMed ID: 33540018
[TBL] [Abstract][Full Text] [Related]
30. Polymeric Microarray Patches for Enhanced Transdermal Delivery of the Poorly Soluble Drug Olanzapine.
McKenna PE; Abbate MTA; Vora LK; Sabri AH; Peng K; Volpe-Zanutto F; Tekko IA; Permana AD; Maguire C; Dineen D; Kearney MC; Larrañeta E; Paredes AJ; Donnelly RF
ACS Appl Mater Interfaces; 2023 Jul; 15(26):31300-31319. PubMed ID: 37349320
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in microneedle-based drug delivery: Special emphasis on its use in paediatric population.
Duarah S; Sharma M; Wen J
Eur J Pharm Biopharm; 2019 Mar; 136():48-69. PubMed ID: 30633972
[TBL] [Abstract][Full Text] [Related]
32. Long-acting transdermal drug delivery formulations: Current developments and innovative pharmaceutical approaches.
Karve T; Dandekar A; Agrahari V; Melissa Peet M; Banga AK; Doncel GF
Adv Drug Deliv Rev; 2024 Jul; 210():115326. PubMed ID: 38692457
[TBL] [Abstract][Full Text] [Related]
33. Mechanistic modeling for optimal design of dissolvable microneedle-based patches for transdermal drug delivery.
Pelaez MJ; Ruiz-Ramirez J; Shen Y; Birur RM; Schiavone C; Cristini V; Puri A; Wang Z; Dogra P
Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38082979
[TBL] [Abstract][Full Text] [Related]
34. Future of the transdermal drug delivery market--have we barely touched the surface?
Watkinson AC; Kearney MC; Quinn HL; Courtenay AJ; Donnelly RF
Expert Opin Drug Deliv; 2016; 13(4):523-32. PubMed ID: 26646399
[TBL] [Abstract][Full Text] [Related]
35. Effect of hydrophilic and hydrophobic polymers on permeation of S-amlodipine besylate through intercalated polymeric transdermal matrix: 3(2) designing, optimization and characterization.
Rastogi V; Yadav P; Husain A; Verma A
Drug Dev Ind Pharm; 2019 Apr; 45(4):669-682. PubMed ID: 30633579
[TBL] [Abstract][Full Text] [Related]
36. A systematic review of medication administration errors with transdermal patches.
Lampert A; Seiberth J; Haefeli WE; Seidling HM
Expert Opin Drug Saf; 2014 Aug; 13(8):1101-14. PubMed ID: 24921682
[TBL] [Abstract][Full Text] [Related]
37. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
Al-Qallaf B; Das DB
Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
[TBL] [Abstract][Full Text] [Related]
38. Electrothermal patches driving the transdermal delivery of insulin.
Pagneux Q; Ye R; Chengnan L; Barras A; Hennuyer N; Staels B; Caina D; Osses JIA; Abderrahmani A; Plaisance V; Pawlowski V; Boukherroub R; Melinte S; Szunerits S
Nanoscale Horiz; 2020 Apr; 5(4):663-670. PubMed ID: 32226966
[TBL] [Abstract][Full Text] [Related]
39. Permeation enhancer strategies in transdermal drug delivery.
Marwah H; Garg T; Goyal AK; Rath G
Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
[TBL] [Abstract][Full Text] [Related]
40. Strategies for transdermal drug delivery against bone disorders: A preclinical and clinical update.
Sharma G; Alle M; Chakraborty C; Kim JC
J Control Release; 2021 Aug; 336():375-395. PubMed ID: 34175368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
